Qiagen N.V. Common Shares (QGEN) analyst actions
Rating and price-target actions on QGEN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the QGEN overview →
2 measured QGEN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Qiagen N.V. (QGEN) And Encourages Shareholders to Reach Out | Press release | +0.17% | +0.51% | |
| QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting | Press release | +0.12% | +0.14% |
Keep exploring
More QGEN: earnings → · SEC filings → · QGEN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
| Eyenovia, Inc. (EYEN) | 266 | -0.95% | 38% |
| 22nd Century Group, Inc (XXII) | 266 | -1.87% | 30% |
| Cellectar Biosciences, Inc. (CLRB) | 265 | +0.27% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.